Low dietary choline and low dietary riboflavin during pregnancy influence reproductive outcomes and heart development in mice

American Journal of Clinical Nutrition

Volumn 91, Issue 4, 2010, Pages 1035-1043

  Chan, Jessica ^a   Deng, Liyuan ^a   Mikael, Leonie G ^a   Yan, Jian ^b   Pickell, Laura ^a   Wu, Qing ^a   Caudill, Marie A ^b   Rozen, Rima ^a  

^a RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; HOMOCYSTEINE; RIBOFLAVIN; LIPOTROPIC AGENT; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); VITAMIN B COMPLEX;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; EMBRYO; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; FEMALE; HEART DEVELOPMENT; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE SEPTUM DEFECT; LIVER; MALE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PREGNANCY; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CONGENITAL HEART MALFORMATION; DIET; DRUG EFFECT; ENZYMOLOGY; FETUS HEART; GENETIC POLYMORPHISM; GENETICS; HEART; MATERNAL NUTRITION; METABOLISM; PREGNANCY OUTCOME; PRENATAL DEVELOPMENT;

MUS;

ANIMALS; CHOLINE; DIET; FEMALE; FETAL HEART; HEART; HEART DEFECTS, CONGENITAL; HOMOCYSTEINE; LIPOTROPIC AGENTS; LIVER; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MICE; MICE, INBRED BALB C; POLYMORPHISM, GENETIC; PREGNANCY; PREGNANCY OUTCOME; PRENATAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; RIBOFLAVIN; VITAMIN B COMPLEX;

EID: 77950505848     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.3945/ajcn.2009.28754     Document Type: Article

References (45)

1. Rosenblatt DS, Fenton W. Inherited disorders of folate and cobalamin transport and metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular basis of inherited disease. 8th ed. New York, NY: McGraw-Hill, 2001:3897-3933
2. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-113
3. Mills JL, McPartlin JM, Kirke PN, et al. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 1995;345: 149-151
4. van der Put NM, Steegers-Theunissen RP, Frosst P, et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995;346:1070-1071
5. Gerhard GT, Duell PB. Homocysteine and atherosclerosis. Curr Opin Lipidol 1999;10:417-428
6. Sohda S, Arinami T, Hamada H, et al. Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia. J Med Genet 1997;34:525-526
7. van Beynum IM, Kapusta L, den Heijer M, et al. Maternal MTHFR 677C>T is a risk factor for congenital heart defects: effect modification by periconceptional folate supplementation. Eur Heart J 2006;27:981-987
8. Hobbs CA, James SJ, Parsian A, et al. Congenital heart defects and genetic variants in the methylenetetrahydrofolate reductase gene. J Med Genet 2006;43:162-166
9. Chen Z, Karaplis C, Ackerman SL, et al. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum Mol Genet 2001;10:433-443
10. Li D, Pickell L, Liu Y, et al. Maternal methylenetetrahydrofolate reductase deficiency and low dietary folate lead to adverse reproductive outcomes and congenital heart defects in mice. Am J Clin Nutr 2005;82: 188-195
11. Schwahn BC, Chen Z, Laryea MD, et al. Homocysteine-betaine interactions in a murine model of 5,10- methylenetetrahydrofolate reductase deficiency. FASEB J 2003;17:512-514
12. Schwahn BC, Laryea MD, Chen Z, et al. Betaine rescue of an animal model with methylenetetrahydrofolate reductase deficiency. Biochem J 2004;382:831-840
13. Zeisel SH. Choline: critical role during fetal development and dietary requirements in adults. Annu Rev Nutr 2006;26:229-250
14. Shaw GM, Carmichael SL, Yang W, et al. Periconceptional dietary intake of choline and betaine and neural tube defects in offspring. Am J Epidemiol 2004;160:102-109
15. Zeisel SH. Biological consequences of choline deficiency. In: Wurtman R, Wurtman J, eds. Choline metabolism and brain function. New York, NY: Raven, 1990:75-99.
16. Fisher MC, Zeisel SH, Mar MH, et al. Inhibitors of choline uptake and metabolism cause developmental abnormalities in neurulating mouse embryos. Teratology 2001;64:114-122
17. Fisher MC, Zeisel SH, Mar MH, et al. Perturbations in choline metabolism cause neural tube defects in mouse embryos in vitro. FASEB J 2002;16:619-621
18. Jacques PF, Kalmbach R, Bagley PJ, et al. The relationship between riboflavin and plasma total homocysteine in the Framingham Off-spring cohort is influenced by folate status and the C677T transition in the methylenetetrahydrofolate reductase gene. J Nutr 2002;132: 283-288
19. McNulty H, Dowey LRC, Strain JJ, et al. Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677C→T polymorphism. Circulation 2006;113:74-80.
20. Nelson MM, Baird CD, Wright HV, et al. Multiple congenital abnormalities in the rat resulting from riboflavin deficiency induced by the antimetabolite galactoflavin. J Nutr 1956;58:125-134
21. Kalter H,Warkany J. Congenital malformations in inbred strains of mice induced by riboflavin-deficient, galactoflavin-containing diets. J Exp Zool 1957;136:531-565
22. Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993;123:1939-1951
23. Li D, Rozen R. Maternal folate deficiency affects proliferation, but not apoptosis, in embryonic mouse heart. J Nutr 2006;136:1774-1778
24. Sepehr E, Peace RW, Storey KB, et al. Folate derived from cecal bacterial fermentation does not increase liver folate stores in 28-d folate-depleted male Sprague-Dawley rats. J Nutr 2003;133:1347-1354
25. Holm PI, Ueland PM, Kvalheim G, et al. Determination of choline, betaine, and dimethylglycine in plasma by a high-throughput method based on normal-phase chromatography-tandem mass spectrometry. Clin Chem 2003;49:286-294
26. Koc H, Mar MH, Ranasinghe A, et al. Quantitation of choline and its metabolites in tissues and foods by liquid chromatography/electrospray ionization-isotope dilution mass spectrometry. Anal Chem 2002;74: 4734-4740
27. Midttun O, Hustad S, Solheim E, et al. Multianalyte quantification of vitamin B6 and B2 species in the nanomolar range in human plasma by liquid chromatography-tandem mass spectrometry. Clin Chem 2005;51: 1206-1216
28. Mikael LG, Genest J Jr, Rozen R. Elevated homocysteine reduces apolipoprotein A-I expression in hyperhomocysteinemic mice and in males with coronary artery disease. Circ Res 2006;98:564-571
29. Roy M, Leclerc D, Wu Q, et al. Valproic acid increases expression of methylenetetrahydrofolate reductase (MTHFR) and induces lower teratogenicity in MTHFR deficiency. J Cell Biochem 2008;105:467-476
30. Li Z, Vance DE. Phosphatidylcholine and choline homeostasis. J Lipid Res 2008;48:1187-1194
31. Zappia V, Zydek-Cwick R, Schlenk F. The specificity of Sadenosylmethionine derivatives in methyl transfer reactions. J Biol Chem 1969;244:4499-4509
32. Shapiro SK, Almenas A, Thomson JF. Biosynthesis of methionine in Saccharomyces cerevisiae. J Biol Chem 1965;240:2512-2518
33. Boot MJ, Steegers-Theunissen RP, Poelmann RE, et al. Cardiac outflow tract malformations in chick embryos exposed to homocysteine. Cardiovasc Res 2004;64:365-373
34. Enaw JO, Zhu H, Yang W, et al. CHKA and PCYTIA gene polymorphisms, choline intake and spina bifida risk in a California population. BMC Med 2006;4:36.
35. Niculescu MD, Yamamuro Y, Zeisel SH. Choline availability modulates human neuroblastoma cell proliferation and alters the methylation of the promoter region of the cyclin-dependent kinase inhibitor 3 gene. J Neurochem 2004;89:1252-1259 (Pubitemid 38715843)
36. Niculescu MD, Craciunescu CN, Zeisel SH. Gene expression profiling of choline-deprived neural precursor cells isolated from mouse brain. Brain Res Mol Brain Res 2005;134:309-322 (Pubitemid 40504145)
37. Yamada K, Chen Z, Rozen R, et al. Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proc Natl Acad Sci USA 2001;98:14853-14858 (Pubitemid 34013934)
38. Burch HB, Combs AM, Lowry OH, et al. Effects of riboflavin deficiency and realimentation on flavin enzymes of tissues. J Biol Chem 1956;223: 29-45.
39. Wallace DC. Mitochondrial DNA mutations in diseases of energy metabolism. J Bioenerg Biomembr 1994;26:241-250 (Pubitemid 24164527)
40. Larsson NG, Oldfors A. Mitochondrial myopathies. Acta Physiol Scand 2001;171:385-393
41. Anan R, Nakagawa M, Miyata M, et al. Cardiac involvement in mitochondrial disease: a study on 17 patients with documented mitochondrial DNA defects. Circulation 1995;91:955-961
42. Wallace DC, Melov S. Radicals r'aging. Nat Genet 1998;19:105-106
43. Towbin JA, Bowles KR, Bowles NE. Etiologies of cardiomyopathy and heart failure. Nat Med 1999;5:266-267
44. Casademont J, Miro O. Electron transport chain defects in heart failure. Heart Fail Rev 2002;7:131-139 (Pubitemid 34624801)
45. Miller Z, Poncet I, Takacs E. Biochemical studies on experimental congenital malformations: flavin nucleotides and folic acid in fetuses and livers from normal and riboflavin-deficient rats. J Biol Chem 1962;237:968-973